Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00977080 · ClinicalTrials.gov registry record · Phase 4
Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D
A Phase 4 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 4
- Development phase
- 272
- Enrollment target
NCT00977080 is a Phase 4 study that has completed, run by Abbott. The registered enrollment target is 272 participants.
The verdict
NCT00977080, a Phase 4 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 272 participants
- Enrollment target
Study Summary
Evaluates the effectiveness of on-label Paricalcitol versus Cinacalcet with Low-Dose Vitamin D.
Interventions
- DRUG Paricalcitol
- DRUG Cinacalcet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 272 participants |
| Start Date | 2009-11 |
| Est. Completion | 2011-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00977080
The ClinicalTrials.gov registry entry for NCT00977080 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 272 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Paricalcitol is the first listed.
NCT00977080 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00977080 about?
NCT00977080 is a clinical study titled "Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D". Evaluates the effectiveness of on-label Paricalcitol versus Cinacalcet with Low-Dose Vitamin D.
What is the current status of trial NCT00977080?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 272 participants. The study started on 2009-11. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00977080?
The interventions under investigation include: Paricalcitol (DRUG), Cinacalcet (DRUG).
Who is sponsoring clinical trial NCT00977080?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.